Sign in
CompletedNo phase

Vitrectomy Versus Suprachoroidal Steroid in Trematodal Granulomatous Uveitis

Key facts

Who runs it
Minia University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
20 Jan 2025
Ended
25 Jul 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Vitrectomy
Record updated
5 August 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Children with history of fresh canal water exposure prior to the onset of uveitis
  • Intermediate uveitis with CB granuloma detected by ultrasound biomicroscopy (UBM)
  • Absence of clinical signs or work-up suggestive of any other cause of granulomatous intermediate uveitis
  • Failure of medical treatment was defined as persistent or recurrent anterior (flare and cells >+1) and/or posterior segment inflammation (>Grade I vitritis) following oral steroids for 8-12 weeks as reported in previous literature

Who cannot take part

  • previous ocular surgery
  • known cause of granulomatous uveitis other than trematodal such as(Tuberculosis, sarcoidosis, Syphilis, toxoplasmosis, toxocariasis, Juvenile idiopathic arthritis)
  • Co-existing ocular pathology that could influence the final visual acuity (VA)
  • Evidence of ocular trauma

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Presumed trematode-induced granulomatous intermediate uveitis (PTIGIU) presents with vitritis and complicated cataract (active stage) which, if left untreated, progresses to tractional retinal detachment (TRD) from the vitreoretinal traction (cicatricial stage) and eventually cilliary body shut down and atrophia bulbi Accordingly, timely diagnosis of such patients during the active stage is essential for early proper management to avoid complications that might eventually result in blindness.

Read full original descriptionShow less

Many treatment modalities for the treatment of AC granulomas were reported, including various combinations of topical corticosteroids, systemic antiparasitic treatment, peribulbar anterior subtenon steroids injections and surgical granuloma excision. Resistant cases may be treated with oral prednisone starting at a daily dose of 1 mg/kg which is gradually tapered over 3-6 weeks . Therefore, many cases may develop steroid-related complications such as cataracts and glaucoma.

This study aims at comparing 6-month visual outcomes and complications after vitrectomy versus suprachoroidal triamcinolone acetonide (SCTA) injection in patient presented with cilliary body granuloma in Presumed trematode-induced granulomatous intermediate uveitis (PTIGIU).

The 2 groups in the trial

  • Vitrectomy armExisting treatment, for comparison

    Pars Plana vitrectomy and debulking of ciliary body granuloma

    Treatment: Vitrectomy

  • Suprachoroidal steroid injectionExisting treatment, for comparison

    Suprachoroida steroid injection of triamcinolone acetonide for ciliary body granuloma.

    Treatment: Vitrectomy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Outcomes of Vitrectomy Versus Suprachoroidal Steroid Injection in Cases of Presumed-trematode Induced Granulomatous Intermediate Uveitis
Record updated
5 August 2025